Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Titel:
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Auteur:
Gronwald, Jacek Robidoux, Andre Kim-Sing, Charmaine Tung, Nadine Lynch, Henry T. Foulkes, William D. Manoukian, Siranoush Ainsworth, Peter Neuhausen, Susan L. Demsky, Rochelle Eisen, Andrea Singer, Christian F. Saal, Howard Senter, Leigha Eng, Charis Weitzel, Jeffrey Moller, Pal Gilchrist, Dawna M. Olopade, Olufunmilayo Ginsburg, Ophira Sun, Ping Huzarski, Tomasz Lubinski, Jan Narod, Steven A.